MTOR and melanoma: The top 8 agents, according to the coefficiency, were JW-7-52-1, Roscovitine (CDK inhibitor), Rapamycin (mTOR inhibitor), CGP-60474 (CDK inhibitor), Erlotinib (EGFR inhibitor), CAL-101 (PI3K inhibitor), STF-62247 (autophagy inducer), Sunitinib (Multi-kinase inhibitor), and melanoma patients with high ICDscore had a dramatically higher IC50 value than those with low ICDscore (Figure 6G–6N).